Smith & Nephew educational grant supports vital role of wound care nurses

  Smith & Nephew educational grant supports vital role of wound care nurses

PR Newswire

ST. PETERSBURG, Fla., April 9, 2014

ST. PETERSBURG, Fla., April 9, 2014 /PRNewswire/ -- Smith & Nephew (NYSE: SNN;
LSE: SN), the global medical technology business, today announces a new
educational relationship with the Wound, Ostomy and Continence Nurses Society
(WOCN®). Through a restricted educational grant, Smith & Nephew is supporting
Wound, Ostomy and Continence (WOC) Nurse Week, which honors the care WOC
nurses provide to millions of patients suffering from chronic wounds, ostomies
and urinary and fecal incontinence.

"Every WOC nurse makes a significant difference in the lives of patients and
their families by directing and providing compassionate care," said Patricia
Burns, a former WOC nurse and now Vice President of Clinical Affairs at Smith
& Nephew. "The WOC nurse requires specialized clinical education to care for
the unique needs of these patients. We want to raise awareness of this nursing
specialty and the contributions it makes."

There is an increasing prevalence of chronic wounds of all types that encumber
patients and health care systems with significant personal and financial
burdens. This creates increased demand for WOC nurses, especially as the
Centers for Medicare and Medicaid Services (CMS) transition to value-based
purchasing, prompting healthcare facilities to carefully implement best
practices and employ specialists to prevent and manage patients' wounds.

A key goal of WOC Nurse Week (April 13 to April 19) is increasing awareness of
the pivotal role WOC nurses play in providing optimal patient care in multiple
healthcare settings. These include inpatient, outpatient, long-term care and
home health. WOC nurses must complete specialized education beyond basic
nursing education, including hands-on clinical training and certification.
They share expert clinical skills, help control costs and ensure compliance
while working toward improved patient care through positive outcomes, advocacy
and the education of patients and families.

"Many chronic wound patients can be cured or at least see marked improvement
with skilled treatment, and it's critically important to continue to train and
support WOC nurses to provide the necessary standard of care for these
conditions," said Burns.

To learn more about the vital role of WOC nurses, please visit

About Smith & Nephew

Smith & Nephew is a global medical technology business dedicated to helping
healthcare professionals improve people's lives. With leadership positions in
Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and
Trauma & Extremities, Smith & Nephew has around 11,000 employees and a
presence in more than 90 countries. Annual sales in 2013 were more than $4.3
billion. Smith & Nephew is a member of the FTSE100 (LSE: SN, NYSE: SNN).

For more information about Smith & Nephew, please visit our corporate website, follow @SmithNephewplc on Twitter or visit
SmithNephewplc on

Forward-looking Statements
This document may contain forward-looking statements that may or may not prove
accurate. For example, statements regarding expected revenue growth and
trading margins, market trends and our product pipeline are forward-looking
statements. Phrases such as "aim", "plan", "intend", "anticipate",
"well-placed", "believe", "estimate", "expect", "target", "consider" and
similar expressions are generally intended to identify forward-looking
statements. Forward-looking statements involve known and unknown risks,
uncertainties and other important factors that could cause actual results to
differ materially from what is expressed or implied by the statements. For
Smith & Nephew, these factors include: economic and financial conditions in
the markets we serve, especially those affecting health care providers, payers
and customers; price levels for established and innovative medical devices;
developments in medical technology; regulatory approvals, reimbursement
decisions or other government actions; product defects or recalls; litigation
relating to patent or other claims; legal compliance risks and related
investigative, remedial or enforcement actions; strategic actions, including
acquisitions and dispositions, our success in performing due diligence,
valuing and integrating acquired businesses; disruption that may result from
transactions or other changes we make in our business plans or organisation to
adapt to market developments; and numerous other matters that affect us or our
markets, including those of a political, economic, business, competitive or
reputational nature. Please refer to the documents that Smith & Nephew has
filed with the U.S. Securities and Exchange Commission under the U.S.
Securities Exchange Act of 1934, as amended, including Smith & Nephew's most
recent annual report on Form 20-F, for a discussion of certain of these
factors. Any forward-looking statement is based on information available to
Smith & Nephew as of the date of the statement. All written or oral
forward-looking statements attributable to Smith & Nephew are qualified by
this caution. Smith & Nephew does not undertake any obligation to update or
revise any forward-looking statement to reflect any change in circumstances or
in Smith & Nephew's expectations.

Trademark of Smith & Nephew. Certain marks registered US Patent and Trademark

SOURCE Smith & Nephew Wound Management

Contact: Investors, Phil Cowdy, +44 (0) 20 7401 7646, Smith & Nephew, or
Media, Beth Bentley, (727) 399-3779, Smith & Nephew; or Taryn Tawoda, (312)
253-7252, Greentarget
Press spacebar to pause and continue. Press esc to stop.